The Weekly Litigation News Digest is now live. Subscribe now

Anti-Ifnar1 Dosing Regime For Subcutaneous Injection - EP4114465

The patent EP4114465 was granted to Astrazeneca on Aug 30, 2023. The application was originally filed on Apr 21, 2022 under application number EP22724683A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP4114465

ASTRAZENECA
Application Number
EP22724683A
Filing Date
Apr 21, 2022
Status
Granted And Under Opposition
Jul 28, 2023
Publication Date
Aug 30, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

MAIWALDMay 29, 2024MAIWALDADMISSIBLE

Patent Citations (22) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONCN113278070
DESCRIPTIONUS10125195
DESCRIPTIONUS7662381
DESCRIPTIONUS7741449
DESCRIPTIONUS9493570
DESCRIPTIONUS9988459
DESCRIPTIONWO2009011770
DESCRIPTIONWO2011028933
DESCRIPTIONWO2013188494
DESCRIPTIONWO2018023976
INTERNATIONAL-SEARCH-REPORTCN113521276B
INTERNATIONAL-SEARCH-REPORTUS2006029601
INTERNATIONAL-SEARCH-REPORTUS2017051066
INTERNATIONAL-SEARCH-REPORTUS2020399381
INTERNATIONAL-SEARCH-REPORTWO2022074123
INTERNATIONAL-SEARCH-REPORTWO2022106460
OPPOSITIONEP3769781
OPPOSITIONWO2021094378
OPPOSITIONWO2021239928
OPPOSITIONWO2022074123
OPPOSITIONWO2022106460
OPPOSITIONWO2022223714

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents